Our priority as investors, in this maze of real-time information overload, is to figure out which of these datapoints and forecasts are relevant. Hence, as always, we have to keep our eye on the ball – and this requires us knowing which of the many balls thrown into the air is the relevant one. Equally important is the timing of our focus on that ball: a view on inflation potentially coming back sometime from 2022 onwards does seem like an easy but not particularly game-changing consideration for what I will be doing now with my portfolio, even as a long-term investor.
In our previous quarterly outlook, we maintained our stance (from earlier this year) that the equity markets of countries that were able to resume their post-Covid-19 economic activity earlier than others would fare relatively better. This meant North Asia was first on our list (which included China, Taiwan and South Korea), followed by Europe. We also believed that it was unlikely that we would have another leg up in equity markets as strong as the one that we had witnessed in the second quarter, especially in the US. We felt that a cooldown period was due, and possibly some profit taking. We argued that the next stage of market upside will have to come from the more cyclical stocks. These, however, needed better visibility on an economic pickup, and that was not evident at the time.
All of our conclusions from our previous outlook remain valid with the caveat that some events have already unfolded. We have now had the pullback, driven by Nasdaq, and North Asia has outperformed both the S&P 500 Index and the Nasdaq Composite Index in US dollars with some help from stronger currencies. Europe, on the other hand, managed to outperform until the first half of September, driven by currency gains, but lost relative performance afterwards as a resurgence of the Covid-19 outbreak spooked markets.
We continue to prefer North Asia, followed by Europe, and we advocate for selective buying in higher-quality value stocks
We continue to prefer North Asia, followed by Europe, and we advocate for selective buying in higher-quality value stocks. We also like sustainability as a theme. While we recognize that there is a lot of noise in the market, we don’t see any new relevant datapoints to reach a different conclusion. So, the question becomes: what matters most right now for our investment decisions and what matters less (or doesn’t matter)?
I see market expectations getting gloomier, and this has affected the performance of European stocks in particular. After the initial shock, macro data in Q3 surprised to the upside compared to very downbeat expectations. The market now fears that the momentum of the recovery is fading and the positive surprises have ended. However, the market may be more concerned about it than it should be.
I don’t believe new and extended lockdowns will stop the recovery as this second wave seems less severe than the first one, at least in Europe. Admittedly, the number of Covid-19 cases has increased significantly, but this is most likely driven by a significant rise in test availability. Mortality rates have meaningfully declined, as vulnerable individuals, medics and governments have a better understanding of how to deal with the disease.
There is also a growing number of effective therapies, two of which are already approved for Covid-19 (Dexamethasone and Remdesivir), two of which are widely available and approved for other indications but not yet for Covid-19 (Tocilizumab and Baricitinib) and two more that are likely to be approved in the near future (one of which, Regeneron’s neutralizing antibodies, was used for President Trump).
Hence, I am not overly concerned if a vaccine will be available in March, April or May from an investment perspective (obviously I am from a human standpoint). The one point that concerns me is the lasting effects of Covid-19 on some companies. The first wave of government support to companies and workers is nearing the end, and new support schemes – even if approved – are likely to be less generous.
Much is being discussed about the possibility of a contested US election but I am more concerned about what will happen in Congress. Clearly, a contested presidential vote would rattle markets in the short term. In the end, however, we will have a president of the United States, and having a winner – independently from who that is – will most likely have markets breathe a sigh of relief.
Either candidate would look to implement stimulus measures for the economy. In the event of a Biden victory, we would likely see a preference for public investment, and more concern for the environment. This would affect stock selection. A split Congress, however, would make any stimulus policy more difficult to implement and – hence – less effective. I would take a contested presidential election any time over a split Congress.
As a portfolio manager trained at the school of value, I have sympathy for investors’ concern about valuations, and the likelihood that in some cases these have run ahead of fundamentals. Yet, the current market polarization implies that not all markets – and certainly not all stocks – have reached nosebleed performance and valuation levels. Over the last ten years, the Nasdaq Composite Index topped the performance of the world’s largest equity markets, followed by the S&P 500 Index. Other markets have vastly underperformed.
Relative valuations are also far more reasonable than the 21x FY20 PE of the US market, with China’s CSI 300 trading at 16.7x FY20 PE and Europe at 16x. Clearly, earnings growth will be the real discriminant, and this is what we need to continue to monitor. Thus far, the differential in the earnings growth outlook between the US, Europe and North Asia does not warrant such disparity in valuations.
Yes, we have hit a road bump. But not an unexpected one. While a second Covid-19 wave is not a blue-sky scenario, it is also not the end of the economic pick-up.
Importantly, we are closer to the end of the sources of uncertainty than to the beginning, whether it is the US elections, a Covid-19 vaccine or the approval of more therapies. Even Brexit, while still unclear, can be pinned down to a range of – admittedly not great – scenarios. This doesn’t mean that it will be plain sailing from here, just that we are either getting past the worst of the typhoon, or that our sails are getting stronger.
Our investment teams have continued to selectively take profit from stocks with stretched valuations and have added to quality laggards that are expected to benefit from recovery in some (but not all) areas of the economy.
For all of the teams, in the choppy waters of macro uncertainty, stock selection has kept the rudder steady. Some stocks will need longer to recover from the post-Covid-19 effects, if they ever will, and it is wise to continue to avoid them until we get more clarity on what the future holds. Importantly, in a news-driven volatile market, staying patient and picking our entry points was and remains the name of the game. Technology stocks remain an overweight in many of the portfolios. This is true also for US technology, although we have been actively lowering the position.
North Asia and Europe remain the largest overweight positions in our global portfolios. Within EM, we are also selective at a country level, and while we have continued to increase our positions in China, Taiwan and South Korea, we remain cautious on Latin American and EMEA economies.
With the many balls being thrown in the air at the moment, keeping our eyes peeled on the relevant one will make the difference in our investment performance.
The contents of this document have not been reviewed by the Securities and Futures Commission ("SFC") in Hong Kong. If you are in any doubt about any of the contents of this document, you should obtain independent professional advice. This document has been distributed by Robeco Hong Kong Limited (‘Robeco’). Robeco is regulated by the SFC in Hong Kong.
This document has been prepared on a confidential basis solely for the recipient and is for information purposes only. Any reproduction or distribution of this documentation, in whole or in part, or the disclosure of its contents, without the prior written consent of Robeco, is prohibited. By accepting this documentation, the recipient agrees to the foregoing
This document is intended to provide the reader with information on Robeco’s specific capabilities, but does not constitute a recommendation to buy or sell certain securities or investment products. Investment decisions should only be based on the relevant prospectus and on thorough financial, fiscal and legal advice. Please refer to the relevant offering documents for details including the risk factors before making any investment decisions.
The contents of this document are based upon sources of information believed to be reliable. This document is not intended for distribution to or use by any person or entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation.
Investment Involves risks. Historical returns are provided for illustrative purposes only and do not necessarily reflect Robeco’s expectations for the future. The value of your investments may fluctuate. Past performance is no indication of current or future performance.
Please read this information carefully.
This website is prepared and issued by Robeco Hong Kong Limited ("Robeco"), which is a corporation licensed by the Securities and Futures Commission in Hong Kong to engage in Type 1 (dealing in securities); Type 4 (advising in securities) and Type 9 (asset management) regulated activities. The Company does not hold client assets and is subject to the licensing condition that it shall seek the SFC’s prior approval before extending services at retail level. This website has not been reviewed by the Securities and Futures Commission or any regulatory authority in Hong Kong.
2. Important risk disclosures
2. Important risk disclosures Robeco Capital Growth Funds (“the Funds”) are distinguished by their respective specific investment policies or any other specific features. Please read carefully for the risks of the Funds:
3. Local legal and sales restrictions
The information contained in the Website is being provided for information purposes.
Neither information nor any opinion expressed on the Website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. The information contained in the Website does not constitute investment advice or a recommendation and was prepared without regard to the specific objectives, financial situation or needs of any particular person who may receive it. An investment in a Robeco product should only be made after reading the related legal documents such as management regulations, prospectuses, most recent annual and semi-annual reports, which can be all be obtained free of charge at www.robeco.com/hk/en and at the Robeco Hong Kong office.
4. Use of the Website
The information is based on certain assumptions, information and conditions applicable at a certain time and may be subject to change at any time without notice. Robeco aims to provide accurate, complete and up-to-date information, obtained from sources of information believed to be reliable. Persons accessing the Website are responsible for their choice and use of the information.
5. Investment performance
No assurance can be given that the investment objective of any investment products will be achieved. No representation or promise as to the performance of any investment products or the return on an investment is made. The value of your investments may fluctuate. The value of the assets of Robeco investment products may also fluctuate as a result of the investment policy and/or the developments on the financial markets. Results obtained in the past are no guarantee for the future. Past performance, projection, or forecast included in this Website should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. Fund performance figures are based on the month-end trading prices and are calculated on a total return basis with dividends reinvested. Return figures versus the benchmark show the investment management result before management and/or performance fees; the fund returns are with dividends reinvested and based on net asset values with prices and exchange rates of the valuation moment of the benchmark.
Investments involve risks. Past performance is not a guide to future performance. Potential investors should read the terms and conditions contained in the relevant offering documents and in particular the investment policies and the risk factors before any investment decision is made. Investors should ensure they fully understand the risks associated with the fund and should also consider their own investment objective and risk tolerance level. Investors are reminded that the value and income (if any) from shares of the fund may be volatile and could change substantially within a short period of time, and investors may not get back the amount they have invested in the fund. If in doubt, please seek independent financial and professional advice.
6. Third party websites
This website includes material from third parties or links to websites maintained by third parties some of which is supplied by companies that are not affiliated to Robeco. Following links to any other off-site pages or websites of third parties shall be at the own risk of the person following such link. Robeco has not reviewed any of the websites linked to or referred to by the Website and does not endorse or accept any responsibility for their content nor the products, services or other items offered through them. Robeco shall have no liability for any losses or damages arising from the use of or reliance on the information contained on websites of third parties, including, without limitation, any loss of profit or any other direct or indirect damage. Third party off-site pages or websites are provided for informational purposes only.
7. Limitation of liability
Robeco as well as (possible) other suppliers of information to the Website accept no responsibility for the contents of the Website or the information or recommendations contained herein, which moreover may be changed without notice.
Robeco assumes no responsibility for ensuring, and makes no warranty, that the functioning of the Website will be uninterrupted or error-free. Robeco assumes no responsibility for the consequences of e-mail messages regarding a Robeco (transaction) service, which either cannot be received or sent, are damaged, received or sent incorrectly, or not received or sent on time.
Neither will Robeco be liable for any loss or damage that may result from access to and use of the Website.
8. Intellectual property
All copyrights, patents, intellectual and other property, and licenses regarding the information on the Website are held and obtained by Robeco. These rights will not be passed to persons accessing this information.
10. Applicable law
The Website shall be governed by and construed in accordance with the laws of Hong Kong. All disputes arising out of or in connection with the Website shall be submitted to the exclusive jurisdiction of the courts of Hong Kong.